Xencor (XNCR) Cash & Current Investments (2013 - 2026)

Xencor's (XNCR) quarterly Cash & Current Investments came in at $384.4 million in Q1 2026, up 334.1% year-on-year from $88.5 million in Q1 2025, and down 11.68% on a QoQ basis from $435.2 million in Q4 2025.

Xencor (XNCR) Cash & Current Investments (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Cash & Current Investments data on file, last reported at $384.4 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 334.1% year-over-year to $384.4 million in Q1 2026; TTM through Mar 2026 was $384.4 million, a 334.1% increase from a year earlier, with the FY2025 full-year figure at $435.2 million, down 3.25% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $384.4 million, down from $435.2 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for XNCR reached as high as $551.5 million in Q4 2023 and fell as low as $59.0 million in Q2 2024.
  • Historically, Cash & Current Investments has averaged $238.0 million across 5 years, with a median of $112.1 million in 2023.
  • Across the five-year window, Cash & Current Investments tumbled 79.54% in 2022 and jumped 583.32% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $96.4 million in 2022, then surged by 472.27% to $551.5 million in 2023, then declined by 18.43% to $449.8 million in 2024, then slipped by 3.25% to $435.2 million in 2025, then decreased by 11.68% to $384.4 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $384.4 million in Q1 2026, $435.2 million in Q4 2025, and $112.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Xencor 1.49 Bn 1.11 Bn - 384.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 384.38 Mn
Dec 31, 2025 435.23 Mn
Sep 30, 2025 112.55 Mn
Jun 30, 2025 403.43 Mn
Mar 31, 2025 88.55 Mn
Dec 31, 2024 449.85 Mn
Sep 30, 2024 464.07 Mn
Jun 30, 2024 59.04 Mn
Mar 31, 2024 75.57 Mn
Dec 31, 2023 551.52 Mn
Sep 30, 2023 465.56 Mn
Jun 30, 2023 74.71 Mn
Mar 31, 2023 112.10 Mn
Dec 31, 2022 96.37 Mn
Sep 30, 2022 84.84 Mn
Jun 30, 2022 76.30 Mn
Mar 31, 2022 111.70 Mn
Dec 31, 2021 180.34 Mn
Sep 30, 2021 88.78 Mn
Jun 30, 2021 161.07 Mn